SLNO- Soleno Therapeutics, Inc.

Name: Soleno Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Soleno Therapeutics, Inc. (SLNO) has 9 insiders with recent SEC Form 4 filings, including 7 buys and 30 sells. SLNO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Anish Bhatnagar	569.5K	$30.19M	-
CFO	MacKaness James H	103.2K	$5.47M	-
Other	Joshi Manher	72.3K	$3.83M	-
Other	Manning Meredith	67.2K	$3.56M	-
Other	Norrett Kevin	64.3K	$3.41M	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 21, 2022	Anish Bhatnagar	Chief Executive Officer	Sell	39,033	$0.37	$14,559.31	-9.5%	-45.1%	-55.9%
Sep 13, 2021	MacKaness James H	Chief Financial Officer	Buy	11,235	$0.89	$9,981.17	+70.0%	-35.8%	-84.2%
May 18, 2021	Schuler Jack W45	10% Owner	Sell	2,072,347	$1.88	$3,902,582.46	-0.8%	-16.8%	-83.0%
Oct 30, 2020	Harris William G	Director	Sell	2,497	$1.74	$4,344.78	-3.6%	-	-
Jun 26, 2020	MacKaness James H	Chief Financial Officer	Buy	6,060	$1.65	$9,999.00	+60.6%	-	-
Jun 26, 2020	Sinclair Andrew	Director	Buy	3,333,330	$1.65	$5,499,994.50	+47.8%	-	-
Jun 26, 2020	Abingworth LLP	10% Owner	Buy	3,333,330	$1.65	$5,499,994.50	+47.8%	-	-
Jun 26, 2020	Schuler Jack W45	10% Owner	Buy	7,575,759	$1.65	$12,500,002.35	+95.3%	-	-
Jun 10, 2020	Schuler Jack W45	10% Owner	Buy	339,083	$1.97	$666,806.72	+19.6%	-	-
Jun 8, 2020	Feinberg Larry N	10% Owner	Sell	200,243	$3.39	$677,880.10	-12.1%	-	-

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC